Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial

Overview of attention for article published in Stroke and Vascular Neurology, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#17 of 333)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 3 news outlets

twitter: 5 tweeters

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News Twitter Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Tranexamic acid fails to prevent ICH growth: TRAIGE trial results

Pediatric News , 03 Sep 2021

Compared with placebo, tranexamic acid did not reduce hematoma growth in patients with intracerebral hemorrhage (ICH), a new…

Tranexamic Acid Fails to Prevent ICH Growth: TRAIGE

Medscape, 01 Sep 2021

Compared with placebo, tranexamic acid did not reduce hematoma growth in patients with intracerebral hemorrhage (ICH), a new…

Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial – MyNeuroNews

MyNeuroNews, 02 Apr 2021

Background Studies show tranexamic acid can reduce the risk of death and early neurological deterioration after intracranial…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.